Masimo’s patent-infringement cases against Apple over technology that measures the amount of oxygen in the wearer’s bloodstream are pending in a California district court and at a US trade agency.
In two separate complaints in the US District Court for the District of Delaware, the Cupertino, Calif.-based tech giant said Masimo “hastily developed” its W1 watch during the litigation, part of “a more nefarious potential strategy” to bump ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
